Take a look back at our most popular news from May 2022.
Did you miss the top stories on Drug Topics® this month? Catch up on these noteworthy stories today.
Communities who are undeserved and vulnerable to COVID-19 were found to be not have much-needed access to test-to-treat location, according to an analysis by the American Pharmacists Association.
Three pharmacists share their stories, challenges, and lessons learned.
This valuable service can make a meaningful difference.
Pharmacists are essential for managing complex CF regimens, monitoring their effectiveness, and improving adherence.
Xolair (omalizumab), Fasenra (benralizumab), Dupixent (dupilumab) and Nucala (mepolizumab) can now be self-administered.
Study shows that 10% of minorities refused COVID-19 vaccines because of past racial discrimination experiences.
Circle 2023 on your calendar. That's when as many as 11 biosimilars to Humira are headed for the US market.
Data from one study showed younger women more likely to use sunscreen than older adults.
Lower household income and requiring multiple medications play large roles.
Pharmacists can improve quality of life for the women they care for by offering advice, education, and other point-of-care services.